Partially-blind (Observer-blind) Study of Safety and Immunogenicity of Two Malaria Vaccines in Ghanaian Children

NCT00360230 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

540

Enrollment

INDUSTRY

Sponsor class

Conditions

Malaria

Interventions

BIOLOGICAL: GSK Biologicals' candidate Plasmodium falciparum malaria vaccine 257049
BIOLOGICAL: Rabipur

Sponsor

GlaxoSmithKline